Banque Cantonale Vaudoise Pacific Biosciences Of California, Inc. Transaction History

Banque Cantonale Vaudoise

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	BUY	$7.94 - $12.02 $21,882 - $33,127	2,756 Added 7.59%	39,046 $452,000
Q4 2022 Feb 10, 2023	BUY	$5.67 - $11.2 $205,764 - $406,448	36,290 New	36,290 $297,000
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $265,147 - $428,277	-11,890 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$26.38 - $51.15 $313,658 - $608,173	11,890 New	11,890 $396,000
Q4 2020 Feb 05, 2021	SELL	$10.5 - $28.5 $57,309 - $155,553	-5,458 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$3.61 - $9.87 $19,703 - $53,870	5,458 New	5,458 $53,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.